Multivariate analysis of prognostic factor
. | Univariate analysis . | Multivariate analysis . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
RFS | ||||||
WBC count <20 × 109/L | 0.415 | 0.216-0.800 | <.001 | 1.113 | 0.474-2.614 | .805 |
Age | 1.017 | 0.998-1.036 | .077 | |||
Not poor cytogenetic prognosis | 1.008 | 0.245-4.148 | .991 | |||
AR <0.5 | 0.460 | 0.255-0.830 | .010 | 0.578 | 0.284-1.178 | .135 |
Presence of NPM1 mut | 1.536 | 0.903-2.614 | .114 | |||
Allo-HSCT at any time | 0.641 | 0.343-1.197 | .163 | NA | NA | NA |
Allo-HSCT at CR1 | 0.083 | 0.030-0.234 | <.001 | 0.066 | 0.020-0.218 | <.001 |
OS | ||||||
WBC count <20 × 109/L | 0.544 | 0.321-0.924 | .024 | 0.754 | 0.376-1.513 | .427 |
Age | 1.039 | 1.023-1.055 | <.001 | 1.033 | 1.016-1.051 | <.001 |
Not poor cytogenetic prognosis | 1.037 | 0.379-2.838 | .944 | |||
AR <0.5 | 0.555 | 0.343-0.898 | .017 | 0.747 | 0.435-1.286 | .293 |
Presence of NPM1 mut | 1.313 | 0.846-2.038 | .225 | |||
Allo-HSCT at any stage | 0.248 | 0.150-0.409 | <.001 | NA | NA | NA |
Allo-HSCT in CR1 | 0.113 | 0.045-0.281 | <.001 | 0.092 | 0.028-0.302 | <.001 |
. | Univariate analysis . | Multivariate analysis . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
RFS | ||||||
WBC count <20 × 109/L | 0.415 | 0.216-0.800 | <.001 | 1.113 | 0.474-2.614 | .805 |
Age | 1.017 | 0.998-1.036 | .077 | |||
Not poor cytogenetic prognosis | 1.008 | 0.245-4.148 | .991 | |||
AR <0.5 | 0.460 | 0.255-0.830 | .010 | 0.578 | 0.284-1.178 | .135 |
Presence of NPM1 mut | 1.536 | 0.903-2.614 | .114 | |||
Allo-HSCT at any time | 0.641 | 0.343-1.197 | .163 | NA | NA | NA |
Allo-HSCT at CR1 | 0.083 | 0.030-0.234 | <.001 | 0.066 | 0.020-0.218 | <.001 |
OS | ||||||
WBC count <20 × 109/L | 0.544 | 0.321-0.924 | .024 | 0.754 | 0.376-1.513 | .427 |
Age | 1.039 | 1.023-1.055 | <.001 | 1.033 | 1.016-1.051 | <.001 |
Not poor cytogenetic prognosis | 1.037 | 0.379-2.838 | .944 | |||
AR <0.5 | 0.555 | 0.343-0.898 | .017 | 0.747 | 0.435-1.286 | .293 |
Presence of NPM1 mut | 1.313 | 0.846-2.038 | .225 | |||
Allo-HSCT at any stage | 0.248 | 0.150-0.409 | <.001 | NA | NA | NA |
Allo-HSCT in CR1 | 0.113 | 0.045-0.281 | <.001 | 0.092 | 0.028-0.302 | <.001 |
HR, hazard ratio; NA, not available.